NCT06501443 - LATAM LOWERS LDL-C | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

November 27, 2026

Study Completion Date

November 29, 2026

Conditions

Hypercholesterolaemia

Interventions

DRUG

Usual care

Treatment after acute event approved in the country where patient is based. It may include educational intervention according to each country guidelines

DRUG

KJX839

Inclisiran in solution for subcutaneous injection on day 1, day 90, and day 270

Trial Locations (11)

30000

RECRUITING

Novartis Investigative Site, Belo Horizonte

W3400

RECRUITING

Novartis Investigative Site, Corrientes

40170-130

RECRUITING

Novartis Investigative Site, Salvador

30110-934

RECRUITING

Novartis Investigative Site, Belo Horizonte

83606-177

RECRUITING

Novartis Investigative Site, Campo Largo

90560 030

RECRUITING

Novartis Investigative Site, Porto Alegre

89010-500

RECRUITING

Novartis Investigative Site, Blumenau

88103-901

RECRUITING

Novartis Investigative Site, São José

15015-110

RECRUITING

Novartis Investigative Site, São José

83430 000

RECRUITING

Novartis Investigative Site, Campina Grande do Sul

40301-155

RECRUITING

Novartis Investigative Site, Salvador